Login
$DCGO
$0.20 +$0.01 (4.27%) After hours

$DCGO 8-K SEC Filings

Filed On Filing
13 Nov 2026 8-K: Departure/Election of Directors or Officers; Compensation

This TRANSITION SERVICES AND SEPARATION AGREEMENT (this “Agreement”) is entered into by and between DocGo Inc., a Delaware corporation (the “Company”), and Lee Bienstock (“Executive”). The Company and Executive are each referred to herei...

09 Nov 2026 8-K: Results of Operations and Financial Condition

Gross Margin Improves 280 Basis Points Over Q2 Due to Company Profitability Initiatives

05 Oct 2026 8-K: Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement +3 more

Perceptive Credit Holdings IV, LP,and its successors and assigns party hereto, as Administrative Agent and as a Lender

17 Aug 2026 8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition

Article 1 THE MERGER................................................................................................................... 3

31 Jul 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On July 28, 2026, DocGo Inc. (the “Company”) received a letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that Nasdaq has granted the Company an additio...

02 Jul 2026 8-K: Regulation FD Disclosure

On June 26, 2026, the Board of Directors of DocGo Inc. (the “Company”) approved an extension of the expiration date of the Company’s current share repurchase program (“Repurchase Program”) from June 30, 2026 to December 31, 2026. As prev...

18 Jun 2026 8-K: Submission of Matters to a Vote of Security Holders

On June 16, 2026, DocGo Inc. (the “Company”) held its 2026 Annual Meeting of Stockholders (the “Annual Meeting”) at 12:00 p.m. Eastern Time. As of the close of business on April 20, 2026, the record date for the Annual Meeting, there wer...

11 May 2026 8-K: Results of Operations and Financial Condition

Company Increases 2026 Revenue Guidance Based on Strong Demand for Virtual Care Services

22 Apr 2026 8-K: Departure/Election of Directors or Officers; Compensation

On April 17, 2026, Stephen K. Klasko, MD notified DocGo Inc. (the “Company”) of his decision to step down as a member of the Board of Directors (the “Board”) and his other Board and committee positions because he accepted a new significa...

16 Mar 2026 8-K: Results of Operations and Financial Condition

Company Raises 2026 Revenue and Adjusted EBITDA Guidance due to Customer Expansions, Improved EMS Hiring Rates and Efficiency Initiatives

30 Jan 2026 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule

On January 26, 2026, DocGo Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid pr...

12 Dec 2025 8-K: Regulation FD Disclosure

On December 12, 2025, the Board of Directors of DocGo Inc. (the “Company”) approved an extension of the expiration date of the Company’s current share repurchase program (“Repurchase Program”) from December 31, 2025 to June 30, 2026. As ...

10 Nov 2025 8-K: Results of Operations and Financial Condition

Company Achieves Record Volumes Across All Major Business Lines

20 Oct 2025 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

Strategic Acquisition Combines DocGo’s Last Mile Healthcare Delivery Capabilities With SteadyMD’s Virtual Care Platform; SteadyMD Is Expected To Generate Approximately $25 Million in Revenue in 2025*

07 Aug 2025 8-K: Results of Operations and Financial Condition

Company Reiterates 2025 Revenue and Adjusted EBITDA Guidance, Increases Total Cash Balance to $128.7 Million, Signs New Contracts Across All Business Verticals

18 Jun 2025 8-K: Submission of Matters to a Vote of Security Holders

On June 17, 2025, DocGo Inc. (the “Company”) held its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) at 12:00 p.m. Eastern Time. As of the close of business on April 21, 2025, the record date for the Annual Meeting, there wer...

12 Jun 2025 8-K: Regulation FD Disclosure

On June 12, 2025, the Board of Directors of DocGo Inc. (the “Company”) approved an extension of the expiration date of the Company’s current share repurchase program (“Repurchase Program”) from June 30, 2025 to December 31, 2025. As prev...

08 May 2025 8-K: Results of Operations and Financial Condition

Company Focuses on Growing Medical Transportation and Payer & Provider Businesses,

27 Feb 2025 8-K: Results of Operations and Financial Condition

Company Surpasses 700,000 Total Patient Lives Assigned for Care Gap Closure Programs and Expands Contracts With Payer Partners on Both Coasts

20 Dec 2024 8-K: Regulation FD Disclosure

On December 20, 2024, the Board of Directors of DocGo Inc. (the “Company”) approved an extension of the expiration date of the Company’s current share repurchase program (“Repurchase Program”) from December 31, 2024 to June 30, 2025. As ...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support